VOYAGER THERAPEUTICS INC (VYGR) Stock Analyst Ratings
USA - NASDAQ:VYGR - US92915B1061 - Common Stock
4.81 USD
+0.16 (+3.44%)
4.8 USD
-0.01 (-0.21%)
ChartMill assigns a Buy % Consensus number of 88% to VYGR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.98. This target is 232.23% above the current price.
VYGR was analyzed by 18 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about VYGR.
In the previous month the buy percentage consensus was at a similar level.
VYGR was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-07 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-04-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-12 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-03-12 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-03-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-10 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-12-02 | Citigroup | Initiate | Buy |
| 2024-11-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-16 | Leerink Partners | Initiate | Outperform |
| 2024-08-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-07 | Wedbush | Maintains | Neutral -> Neutral |
| 2024-07-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-14 | Wedbush | Maintains | Neutral -> Neutral |
| 2024-03-26 | Guggenheim | Initiate | Buy |
| 2024-03-19 | HC Wainwright & Co. | Initiate | Buy |
| 2024-03-07 | Citigroup | Initiate | Buy |
| 2024-01-02 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2023-08-07 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-05-10 | Truist Securities | Initiate | Buy |
| 2023-05-10 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-03-10 | Oppenheimer | Initiate | Outperform |
VOYAGER THERAPEUTICS INC / VYGR FAQ
What is the price target for VYGR stock?
18 analysts have analysed VYGR and the average price target is 15.98 USD. This implies a price increase of 232.22% is expected in the next year compared to the current price of 4.81.
How do analysts rate VOYAGER THERAPEUTICS INC (VYGR)?
The consensus rating for VOYAGER THERAPEUTICS INC (VYGR) is 87.7778 / 100 . This indicates that analysts generally have a positive outlook on the stock.